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Abstract 
Objectives Oxycodone is semi-synthetic opioid, oral and parenteral preparations have been widely 
used for acute and chronic pain. The aim of this study was to assess the efficacy and side effects of 
oxycodone and fentanyl in patient controlled analgesia (PCA) after laparoscopic cholecystectomy. 
Methods A prospective, randomized, double-blind study was conducted. 81 patients were ran-
domly divided into two groups; fentanyl (10 mcg fentanyl and 1.5 mg ketorolac) and oxycodone 
group (1 mg oxycodone and 1.5 mg ketorolac). After the operation, a blinded observer assessed 
pain using a numerical rating scale (NRS), infused PCA dose, side effects, sedation levels, and 
satisfaction. 
Results Cumulative PCA dose of oxycodone group at 48 h (31.4 ± 16.0 ml) was significantly less 
than that of fentanyl group (43.8 ± 23.1 ml, P = 0.009). Oxycodone group showed more nausea at 
6 - 24 h after the operation (P = 0.001), but there was no difference in satisfaction score (P = 
0.073). There were no significant differences in other side effects, sedation and NRS scores be-
tween two groups.  
Conclusion Oxycodone showed comparable effects for pain relief compared to fentanyl in spite of 
less cumulative PCA dose. Based on these results, we could conclude that oxycodone may be 
useful as an alternative to fentanyl for PCA after laparoscopic cholecystectomy. 
Key words: Fentanyl, Laparoscopic cholecystectomy surgery, Oxycodone, Patient-controlled an-
algesia, Postoperative pain. 
Introduction 
Laparoscopic cholecystectomy surgery is often 
accompanied by severe pain, although it has ad-
vantages of fast recovery, reduced postoperative pain, 
and short hospital stay [1,2]. Postoperative pain can 
cause atelectasis, sympathetic over activity, prolonged 
hospital stay, and decreased patient’s satisfaction. 
Furthermore, unrelieved severe pain may lead to 
chronic pain. Patient-controlled analgesia (PCA), 
which allows a patient to administer their own pain 
relief, is known to provide an efficient way to control 
postoperative pain [3]. A variety of analgesics in-
cluding non-steroidal anti-inflammatory drugs 
(NSAIDs) and opioids have been used for the PCA. 
Not only the efficacy of a drug, but also its side effects, 
duration, and patient’s history or general condition 
are critical factors to be considered in selecting an 
opioid. The pharmacodynamic and pharmacokinetic 
effects depend on the type of opioids, route, age, ge-
netic polymorphism, and so on [4,5].  
Oxycodone is one of the most widely used opi-
oids for pain management [6,7]. There have been 
several studies on the efficacy and side effects of ox-
ycodone. Oxycodone has been known to have the 








demonstrated good efficacy of oxycodone on postop-
erative pain [9-11]. However, most of the previous 
studies are based on oral oxycodone and bolus intra-
venous injection of oxycodone. The equivalent dose of 
oxycodone to fentanyl has not been clarified, espe-
cially in PCA. 
In this study, we designed a prospective, ran-
domized, and double-blind study to assess the effi-
cacy and side effects of oxycodone PCA compared to 
those of fentanyl PCA in patients who underwent the 
laparoscopic cholecystectomy. 
Materials and methods 
Study design 
A prospective, randomized and double-blind 
study was conducted at the Department of Anesthesia 
and Pain Medicine at Pusan National University 
Hospital, Korea between June and October 2013. The 
study protocol was approved by an appropriate in-
stitutional review board (IRB), and patients were 
provided informed consent before a surgery.  
Subjects 
90 patients who are ASA class I or II were 
scheduled for laparoscopic cholecystectomy. Patients 
of both genders, aged 18 to 65 years old, were select-
ed. Patients, who do not qualify for or do not prefer 
treatment of opioids or NSAIDs, or who have psy-
chological disorder, chronic pain disorder or pre-
operative administration of drugs including opioids, 
antidepressants, gabapentin, pregabalin, and car-
bamazepine, were excluded. Patients, who cannot use 
numerical rating scale (NRS), who have increased 
intracranial pressure, renal failure, hepatic failure, or 
in pregnancy, were also excluded. 
Treatment 
The primary end point was to compare efficacy 
with oxycodone and ketorolac versus fentanyl and 
ketorolac. Secondary outcomes were incidences of 
side-effects and patients’ satisfaction. Patients were 
randomly divided into fentanyl group and oxycodone 
group. Fentanyl group received 10 mcg fentanyl and 
1.5 mg ketorolac, and oxycodone group received 1 mg 
oxycodone and 1.5 mg ketorolac for a bolus dose. 
Anesthesia was standardized in both groups. 0.2 mg 
glycopyrrolate was intramuscularly injected to all the 
patients 30 min before induction of anesthesia. After 
patients arrived in the operating room, their baseline 
heart rate, mean arterial blood pressure, oxygen sat-
uration were obtained using patient monitor. Bispec-
tral index (BIS, XP version 4.1; Aspect Medical Sys-
tems, Newton, MA, USA) monitoring was used to 
measure the depth of anesthesia. 2 mg/kg i.v. 
propofol, 0.6 mg/kg i.v. rocuronium, and 0.5 
mcg/kg/min i.v. remifentanil were administered for 
the induction, and sevoflurane was used for mainte-
nance. 30 mcg fentanyl/4.5 mg ketorolac or 3 mg ox-
ycodone/4.5 mg ketorolac were administered in the 
fentanyl or the oxycodone groups, respectively, and 
an antiemetic was administered 30 min before the end 
of surgery. After the operation, 10 mg i.v. pyri-
dostigmine and 0.4 mg i.v. glycopyrrolate were ad-
ministered, and patients were transferred to 
post-anesthesia care unit, and stayed until Aldrete 
score was greater than 8. Patients received pain con-
trol via PCA with a bolus dose of 1 ml, a lock-out in-
terval of 6 min, and a four-hour limit of 40 ml. If pa-
tients complained severe pain above 5, we recom-
mended them to press the button instead of admin-
istration of rescue analgesics. 
Assessment 
A blinded observer assessed the pain at rest and 
during coughing based on an NRS, where 0 denotes 
no pain and 10 denotes worst pain experienced. Cu-
mulative PCA dose and sedation scale were also 
measured at 1, 4, 8, 12, 24, and 48 h after the operation. 
The Ramsay sedation scale was applied to assess the 
sedation state: 1 = anxious, agitated, or restless; 2 = 
cooperative, oriented, and tranquil; 3 = responds to 
command; 4 = brisk response to a light glabellar tap or 
loud auditory stimulus; 5 = sluggish response to a 
light glabellar tap or loud auditory stimulus; and 6 = 
no response to the stimuli. 
Side-effects were recorded at 6, 24, and 48 h after 
the surgery. If a patient complained severe nausea, 4 
mg i.v. ondansetron was injected. Patients were asked 
to rank their satisfaction according to the following 
scale: 1 = very unsatisfactory; 2 = unsatisfactory; 3 = 
neutral; 4 = satisfactory; 5 = very satisfactory. 
Statistical analysis 
Data are expressed as mean ± SD. The demo-
graphic data were compared using the student’s t-test. 
Incidence of side effects was compared between two 
groups using the chi-square test and Mann-Whitney 
test. The cumulative PCA dose and the sedation 
scores were compared using Mann-Whitney test. The 
NRS were compared using two-way repeated 
measures ANOVA. The satisfaction scores of two 
groups were compared using the chi-square test. A 
probability of < 0.05 was considered to be significant. 
SPSS (21.0 IBM statistics data editor SPSS Inc., Chi-
cago, IL, USA) was used for all statistical analyses. An 
estimated sample size indicated that 41 patients per 
group would give a β-risk of 80% at an α-level of 0.05 
for detecting a difference in cumulative PCA dose (35 
vs 40 ml) of at least 5 ml at 48 h after the operation 
with a standard deviation of 8.0 for each group in the 




preliminary test. We enrolled 90 subjects for study 
considering 10% as exclusion rate.  
Results 
90 patients were assessed for the study. 4 pa-
tients refused the participation in the study, and 86 
patients were included in this study after randomiza-
tion. A patient of each group was discharged earlier 
than expected, and 2 patients of fentanyl group and 1 
patient of oxycodone group wanted early discontinu-
ation of PCA for emesis. 
There was no significant difference between the 
two groups in the distribution of height, weight, age, 
and sex (Table 1). 
Side-effects such as vomiting, headache, shiver-
ing, pruritus, and respiratory depression in the ox-
ycodone group were not significantly different from 
those in the fentanyl group. However, the patients in 
the oxycodone group experienced more nausea at 6-24 
h after operation compared to the fentanyl group (P = 
0.002, Table 2).  
 
Table 1: Baseline demographic characteristics of patients. 
Characteristics Fentanyl Oxycodone Total 
Sex    
Male 21 21 42 
Female 19 20 39 
Age, mean years (SD) 54.4 (13.8) 49.6 (15.0) 52.0 (14.5) 
Weight, mean kg (SD) 63.6 (10.865) 67.8 (14.2) 65.7 (12.7) 
Height, mean cm (SD) 164.4 (8.909) 164.4 (10.4) 164.7 (9.6) 
There is no significant difference between groups. 
 
Table 2: Incidence of side effects. 
Side effects Fentanyl Oxycodone Total P value 
Nausea, n (%) 14 (35) 22 (53.7) 36 (44.4) 0.091 
< 6 h 14 (35) 18 (43.9) 32 (39.5) 0.413 
6 – 24 h 5 (12.5) 18 (43.9) 23 (28.4) 0.002 
24 h < 4 (10) 3 (7.3) 7 (8.6) 0.667 
Vomiting 0 (0) 0 (0) 0 (0) - 
Headache, n (%) 1 (2.5) 2 (4.9) 3 (3.7) 0.571 
Shivering, n (%) 0 (0) 1 (2.4) 1 (1.2) 0.320 
Pruritus, n (%) 3 (7.5) 1 (2.4) 4 (4.9)  0.293 
Respiratory depression, n (%) 0 (0) 0 (0) 0 (0) - 
The oxycodone group patients experienced more nausea at 6-24 h after operation 
compared to the fentanyl group (P = 0.002, Chi square test). 
 
 
The cumulative PCA doses were measured at 1, 
2, 4, 8, 12, 24, and 48 h after the operation. The ox-
ycodone group showed significantly less amount of 
cumulative PCA dose compared to the fentanyl group 
after 8 h (P < 0.05, Figure 1). Cumulative PCA dose of 
oxycodone group at 48 h (31.4 ± 16.0 ml) was signifi-
cantly less than that of fentanyl group (43.8 ± 23.1 ml, 
P = 0.009). Six patients in fentanyl group and ten pa-
tients in oxycodone group who complained severe 
emesis were administrated ondansetron intravascu-
larly. Percentage of severe cases in total nausea of 
fentanyl group and oxycodone group were 42.9% and 
47.6%. There was no significant difference in admin-
istration of ondansetron between both groups. 
Sedation levels of the patients were assessed 
based on the Ramsey sedation scale. The patients in 
both groups showed similar sedation levels (Figure 2). 
There was no significant difference in NRS at rest 
and during coughing between the two groups and 
they decreased in process of time from 4 to 48 h (Fig-
ure 3a and 3b). 
There was no significant difference in satisfac-
tion score at 48 h after the operation (P=0.073, Table 
3). 
 
Figure 1: Cumulative PCA dose measured at several time points between 
1 and 48 h after the operation. The patients of fentanyl group show higher 
consumption rate than the patients of oxycodone group. Data are ex-




Figure 2: Ramsey sedation scores at several time points between 1 and 48 
h after the operation. Both groups show similar sedation levels. Data are 
expressed as mean ± SD. 
 
Table 3: Satisfaction on pain management at 48 hr. 
Satisfaction, n (%) Fentanyl Oxycodone Total 
1 0 (0) 0 (0) 0 (0) 
2 3 (7.5) 0 (0) 3 (3.7) 
3 8 (20) 7 (17.1) 15 (18.5) 
4 22 (55) 18 (43.9) 40 (49.4) 
5 7 (17.5) 16 (39) 23 (28.4) 
There is no significant difference in satisfaction score at 48 h after the operation 
between groups (P=0.073, Chi square test). 
 





Figure 3: Numerical rating scale (NRS) of pain at 1 - 48 h after the 
operation. The NRS of pain intensity was assessed (a) at rest and (b) during 
coughing. There is no significant difference between both groups. Both 
groups show marked decrease in pain as the time passed. Data are ex-
pressed as mean ± SD. 
 
Discussion 
There have been many studies comparing the 
effect of different opioids on acute post-operative 
pain. No previous study has compared oxycodone 
and fentanyl in PCA. We showed that oxycodone 
group needed less cumulative PCA doses compared 
to fentanyl group, while analgesic effects were not 
different. 
Oxycodone is a semi-synthetic opioid and oral 
oxycodone has been widely used for treatment for 
postoperative pain, chronic pain, and pain due to ma-
lignant disease [6, 7]. Parenteral oxycodone appears to 
be equipotent with morphine [8]. Morphine has a 
1:80-100 potency ratio compared to fentanyl [12]. In 
this study, however, the oxycodone group showed 
significantly less cumulative PCA dose to maintain 
the NRS values comparable with that of the fentanyl 
group. Mean cumulative PCA dose of the oxycodone 
group was 31.4 ml at 48h after operation, while that of 
the fentanyl group was 43.8 ml. Therefore, we could 
suggest that the potency ratio of fentanyl to oxyco-
done might be around 1:75 and oxycodone might be 
more potent than morphine (4:3). Similarly, there 
have been several literatures supporting that oxyco-
done is more potent than morphine. Lenz et al. [10] 
have suggested that the equianalgesic efficacy of ox-
ycodone is 1.6 times higher than that of morphine. It 
has been reported that oxycodone provides better 
analgesia but also more side effects on bolus injection 
[11]. It has also been known that oxycodone have 
more effective to visceral pain than other opioids [13]. 
Kalso et a l. [14] observed that less oxycodone was 
needed for the pain relief than morphine.  
It is too early to conclude that oxycodone of 1 mg 
is more potent or effective than fentanyl 100mcg or 
morphine 1mg. We should consider other factors such 
as distribution, clearance, bioavailability, and dura-
tion of the drugs. Kalso et al. [14] also suggested that 
the parenteral oxycodone provided fast and 
long-lasting pain relief as compared to morphine. 
Oxycodone has a slightly longer duration of action 
when compared with fentanyl (t1/2: 4 h 52 min vs. 3 h 
39 min). The analgesic effect of a single dose of i.v. 
fentanyl may be shorter because of redistribution [11]. 
In this study, the similar analgesic potency was noted 
during very early postoperative period. Effect of the 
opioid duration on the PCA consumption is uncer-
tain, because we did not evaluate the time to the first 
bolus injection after administrating loading dose. 
There is a possibility that the longer action duration of 
oxycodone compared to fentanyl saved the cumula-
tive consumption of opioids.  
The pain intensity of both groups decreased as 
time went on, thus the cumulative opioid dose also 
decreased. This result implies that the pain manage-
ment during the acute phase is critical. Severe acute 
pain may lead to chronic pain. Therefore, preemptive 
and aggressive postoperative multimodal analgesia is 
required [15]. Most patients complained of pain dur-
ing acute phase, and the NRS of the pain intensity was 
over 5 at 1 h after the operation. Initial bolus doses of 
oxycodone and fentanyl group were 3 mg and 30 mcg 
in this study. Therefore, we suggest that bolus dose 
should be increased or another rescue drugs are nec-
essary in the acute period.  
Most nausea occurred within 24 h, and it de-
creased as the time passed. There was no difference in 
nausea occurrence until 6 h after operation. The nau-
sea before 6 h might be due to inhalation agents, lap-
aroscopic surgery, severe acute pain, gastroparesis, 
and so on [16]. The incidence rate of nausea at 6-24 h 
after operation in the oxycodone group was higher 
than that in the fentanyl group although the cumula-
tive PCA dose in the oxycodone group was lower 
than that in the fentanyl group. Similar to our results, 
Pedersen et al. [17] demonstrated that morphine and 
oxycodone produced similar analgesia after percuta-
neous kidney stone surgery, but the nausea occurred 
more frequently in the treatment of oxycodone com-
pared to morphine. Low doses of opioids activate mu 
opioid receptors in the chemoreceptor trigger zone 
(CTZ), thereby stimulating vomiting. Oxycodone and 




fentanyl share mu opioid receptor [18]. We guess that 
the longer duration and larger dose administration for 
bolus injection in oxycodone group induced more 
frequent nausea. 
In this study, fifty percents of all patients 
showed nausea, so it seems to require a routine ad-
ministration of antiemetics or more careful manage-
ment of the PCA setting. This result was unexpected 
that the satisfaction of oxycodone group was similar 
with fentanyl group although the incidence of nausea 
was higher in oxycodone group. It might be due to 
longer duration and higher efficacy for one bolus dose 
in oxycodone, and nausea subsided quickly by 4 mg 
i.v. ondansetron. This result implies that oxycodone 
could be useful for PCA to manage postoperative 
pain. 
In this study, ketorolac (1.5 mg/ml in concentra-
tion) was mixed to PCA solution. Ketorolac has been 
known to reduce opioid consumption and opioid re-
lated side effects [19]. Ketorolac -induced side effects 
such as increased bleeding tendency and renal toxicity 
did not occur in this limited number of patients. 
Maximum cumulative dose of ketorolac were 150 mg 
and 133 mg in fentanyl and oxycodone group for 48 
hrs and did not exceed daily recommended dosage.  
In this study, the cumulative PCA dose does not 
mean how many times patients press the button, be-
cause we adjusted the lock-out interval as 6 min. If we 
allowed the patients to shorten lock-out interval, the 
differences between the cumulative PCA doses of two 
groups might be widen. In addition, the target of this 
study was healthy adults in both genders, thus the 
effects of bioavailability, metabolism, genetic poly-
morphism, underlying disease, and type of operations 
have not been investigated. Recent study suggests 
that there is a significant interindividual variation in 
the need for oxycodone for sufficient analgesia [20]. 
Therefore, further evaluation and study about ox-
ycodone for PCA should be conducted.  
Oxycodone showed comparable effects for pain 
relief compared to fentanyl in spite of less cumulative 
PCA dose. Based on these results, we could conclude 
that oxycodone may be useful as an alternative to 
fentanyl for PCA after laparoscopic cholecystectomy. 
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